Successful application of belimumab in two patients with systemic lupus erythematosus experiencing a flare during tocilizumab treatment

Co-stimulatory molecules as targets for treatment of lupus

(2013) Joan T. Merrill   CLINICAL IMMUNOLOGY

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

(2012) Ronald F van Vollenhoven et al.   ANNALS OF THE RHEUMATIC DISEASES

Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor

(2012) Iris Navarro-Millán et al.   CLINICAL THERAPEUTICS

Therapeutic blockade of TNF in patients with SLE—Promising or crazy?

(2011) Martin Aringer et al.   AUTOIMMUNITY REVIEWS

Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach

(2011) Leonid Gibiansky et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

(2010) Gabor G. Illei et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM